Extracellular targets for Alzheimer's disease

Details for Australian Patent Application No. 2008306839 (hide)

Owner VIB vzw Katholieke Universiteit Leuven, K.U. Leuven R & D

Inventors Wakabayashi, Tomoko; De Strooper, Bart

Agent Davies Collison Cave

Pub. Number AU-A-2008306839

PCT Pub. Number WO2009/043922

Priority 60/998,017 04.10.07 US

Filing date 3 October 2008

Wipo publication date 9 April 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/043922 Priority application(s): WO2009/043922

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008306846-Mechanical protective layer for solid dosage forms

2008306838-Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants